Literature DB >> 22317840

Management of infective endocarditis: challenges and perspectives.

Franck Thuny1, Dominique Grisoli2, Frederic Collart2, Gilbert Habib3, Didier Raoult4.   

Abstract

Despite improvements in medical and surgical therapies, infective endocarditis is associated with poor prognosis and remains a therapeutic challenge. Many factors affect the outcome of this serious disease, including virulence of the microorganism, characteristics of the patients, presence of underlying disease, delays in diagnosis and treatment, surgical indications, and timing of surgery. We review the strengths and limitations of present therapeutic strategies and propose future directions for better management of endocarditis according to the most recent research. Novel perspectives on the management of endocarditis are emerging and offer hope for decreasing the rate of residual deaths by accelerating the process of diagnosis and risk stratification, reducing delays in starting antimicrobial therapy, rapid transfer of high-risk patients to specialised medico-surgical centres, development of new surgical methods, and close long-term follow-up. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22317840     DOI: 10.1016/S0140-6736(11)60755-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  108 in total

1.  Long-term antibiotic therapy in patients with surgery-indicated not undergoing surgery infective endocarditis.

Authors:  Nuria Vallejo Camazon; Lourdes Mateu; Germán Cediel; Laura Escolà-Vergé; Nuria Fernández-Hidalgo; Mercedes Gurgui Ferrer; Maria Teresa Perez Rodriguez; Guillermo Cuervo; Raquel Nuñez Aragón; Cinta Llibre; Nieves Sopena; Maria Dolores Quesada; Elisabeth Berastegui; Albert Teis; Jorge Lopez Ayerbe; Gladys Juncà; Francisco Gual; Elena Ferrer Sistach; Ainhoa Vivero; Esteban Reynaga; Maria Hernández Pérez; Christian Muñoz Guijosa; Lluisa Pedro-Botet; Antoni Bayés-Genís
Journal:  Cardiol J       Date:  2021-05-25       Impact factor: 2.737

2.  Trends in hospitalization rates and outcomes of endocarditis among Medicare beneficiaries.

Authors:  Behnood Bikdeli; Yun Wang; Nancy Kim; Mayur M Desai; Vincent Quagliarello; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2013-08-28       Impact factor: 24.094

3.  Streptococcus bovis bacteraemia: an evaluation of the long-term effect on cardiac outcomes.

Authors:  Gerard J Fitzmaurice; Adrian J McKenna; Jamie Murphy; Ronan McMullan; Mark E O'Donnell
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-09-11

4.  Infective Endocarditis in French West Indies: A 13-Year Observational Study.

Authors:  Elisabeth Fernandes; Claude Olive; Jocelyn Inamo; François Roques; André Cabié; Patrick Hochedez
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

5.  The risk of infective endocarditis in the 21st century.

Authors:  Nalini M Rajamannan
Journal:  Indian Heart J       Date:  2013-07-25

6.  Effect of cerebral embolus size on the timing of cardiac surgery for infective endocarditis in patients with neurological complications.

Authors:  Yong Kyun Kim; Choong Gon Choi; Jiwon Jung; Shi Nae Yu; Ju Young Lee; Yong Pil Chong; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; Jun Hee Woo; Yang Soo Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-06       Impact factor: 3.267

7.  Reappraisal of a single-centre policy on the contemporary surgical management of active infective endocarditis.

Authors:  Frank Caes; Thierry Bové; Yves Van Belleghem; Guy Vandenplas; Guido Van Nooten; Katrien François
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-10-30

8.  Prosthetic valve endocarditis due to Propionibacterium acnes.

Authors:  Richard van Valen; Robert A F de Lind van Wijngaarden; Nelianne J Verkaik; Mostafa M Mokhles; Ad J J C Bogers
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-04-06

9.  The relationship of the lipoprotein SsaB, manganese and superoxide dismutase in Streptococcus sanguinis virulence for endocarditis.

Authors:  Katie E Crump; Brian Bainbridge; Sarah Brusko; Lauren S Turner; Xiuchun Ge; Victoria Stone; Ping Xu; Todd Kitten
Journal:  Mol Microbiol       Date:  2014-05-12       Impact factor: 3.501

10.  Infective endocarditis in Rio de Janeiro, Brazil: a 5-year experience at two teaching hospitals.

Authors:  P V Damasco; J N Ramos; J C D Correal; M V Potsch; V V Vieira; T C F Camello; M P Pereira; V D Marques; K R N Santos; E A Marques; M B Castier; R Hirata; A L Mattos-Guaraldi; C Q Fortes
Journal:  Infection       Date:  2014-06-17       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.